✦ LIBER ✦
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
✍ Scribed by Karen A Gelmon; Marc Tischkowitz; Helen Mackay; Kenneth Swenerton; André Robidoux; Katia Tonkin; Hal Hirte; David Huntsman; Mark Clemons; Blake Gilks; Rinat Yerushalmi; Euan Macpherson; James Carmichael; Amit Oza
- Book ID
- 117785755
- Publisher
- The Lancet
- Year
- 2011
- Tongue
- English
- Weight
- 264 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.